Disseminated Intravascular Coagulation

2016 ◽  
Vol 125 (1) ◽  
pp. 230-236 ◽  
Author(s):  
Jecko Thachil

Abstract Anesthesiologists may encounter patients with disseminated intravascular coagulation, a potential complication of severe sepsis or major trauma. This practical guide discusses the clinical approach, laboratory diagnosis, and current management of this condition.

1968 ◽  
Vol 50 (2) ◽  
pp. 211-220 ◽  
Author(s):  
Isadore Brodsky ◽  
Arthur N. Meyer ◽  
S. Benham Kahn ◽  
Evelyn M. Ross

2001 ◽  
Vol 82 (2) ◽  
pp. 122-127
Author(s):  
I. I. Litvinov ◽  
G. M. Kharin

In the development of many diseases and pathological conditions, an important role belongs to hemocoagulation disorders, which are often realized in the form of clinical and laboratory symptoms combined into disseminated intravascular coagulation syndrome (DIC). Much fundamental research has been devoted to the study of the biochemical and morphological manifestations of this syndrome [2, 3, 5, 6], but the data presented are often contradictory, and with the advent of new theoretical concepts and methodological techniques, they require revision. Adequate laboratory diagnosis of DIC should be based on a clear understanding of its pathogenesis, without which the correct interpretation of the variable and sometimes paradoxical results of laboratory diagnostic studies is impossible.


1970 ◽  
Vol 20 (1) ◽  
pp. 68-74 ◽  
Author(s):  
S Sultana ◽  
A Begum ◽  
MA Khan

Disseminated intravascular coagulation (DIC) is an acquired and complex disorder that occurs in a wide variety of clinical conditions. This is basically a state of increased propensity for clot formation triggered by a variety of stimuli related to such diverse disorders as sepsis, endothelial cell damage (heat stroke, shock), obstetrical complication (abruptio placenta, amniotic fluid embolism, severe preeclampsia and retained intrauterine dead foetus) and neoplasm. DIC is a classic complication of obstetric conditions occurring in more than 50 percent of patients with obstetric causes. In DIC, an unregulated thrombin explosion cause release of free thrombin into the circulation that leads to the clinical features of DIC, with thrombin and plasmin responsible for the thrombotic and haemorrhagic manifestations, respectively. The diagnosis and treatment of this syndrome require an understanding of its pathophysiology, awareness of the disorders that can trigger it and its early recognition. Acute DIC is usually associated with infections, the commonest cause, about 10-20% of patients with gram negative sepsis have evidence of DIC. Chronic DIC is usually associated with retained dead fetus, carcinomatosis. The diagnosis of this syndrome is essentially clinical, with laboratory tests providing confirmatory evidence. Microvascular thrombosis is the primary mechanism in most cases, and end organ failure is a major cause of death. No single diagnostic test exists for DIC. DIC is initially suggested by the following combination; a clinical condition consistent with DIC, thrombocytopenia, prolonged PT, APTT, and presence of FDP/D-dimer. Medical treatment depends on the cause of the DIC. Basically it involves removing the cause for example, delivery of placenta if it is retained or abrupted, delivery of foetus if retained, quick delivery if severe eclampsia and so on, hysterectomy if bleeding can not be controlled from placental site. After then, and/or con-currently treat DIC with blood and plasma transfusions and appropriate supportive measures. As the sequel of DIC can be devastating, early clinical suspicion and laboratory diagnosis are essential. This review article provides essential guideline for the appropriate diagnosis and clinical management of DIC in obstetric patients. Key words: Disseminated intravascular coagulation (DIC); Obstetric; Thrombosis; Fibrin; Ddimer; FDP; Anticoagulant. DOI: http://dx.doi.org/10.3329/jdmc.v20i1.8585 J Dhaka Med Coll. 2011; 20(1) :68-74  


2019 ◽  
Vol 178 ◽  
pp. 182-188 ◽  
Author(s):  
Satoshi Gando ◽  
Atsushi Shiraishi ◽  
Kazuma Yamakawa ◽  
Hiroshi Ogura ◽  
Daizoh Saitoh ◽  
...  

2018 ◽  
Vol 24 (9_suppl) ◽  
pp. 8S-28S ◽  
Author(s):  
Chrysoula Papageorgiou ◽  
Georges Jourdi ◽  
Eusebe Adjambri ◽  
Amanda Walborn ◽  
Priya Patel ◽  
...  

Disseminated intravascular coagulation (DIC) is an acquired clinicobiological syndrome characterized by widespread activation of coagulation leading to fibrin deposition in the vasculature, organ dysfunction, consumption of clotting factors and platelets, and life-threatening hemorrhage. Disseminated intravascular coagulation is provoked by several underlying disorders (sepsis, cancer, trauma, and pregnancy complicated with eclampsia or other calamities). Treatment of the underlying disease and elimination of the trigger mechanism are the cornerstone therapeutic approaches. Therapeutic strategies specific for DIC aim to control activation of blood coagulation and bleeding risk. The clinical trials using DIC as entry criterion are limited. Large randomized, phase III clinical trials have investigated the efficacy of antithrombin (AT), activated protein C (APC), tissue factor pathway inhibitor (TFPI), and thrombomodulin (TM) in patients with sepsis, but the diagnosis of DIC was not part of the inclusion criteria. Treatment with APC reduced 28-day mortality of patients with severe sepsis, including patients retrospectively assigned to a subgroup with sepsis-associated DIC. Treatment with APC did not have any positive effects in other patient groups. The APC treatment increased the bleeding risk in patients with sepsis, which led to the withdrawal of this drug from the market. Treatment with AT failed to reduce 28-day mortality in patients with severe sepsis, but a retrospective subgroup analysis suggested possible efficacy in patients with DIC. Clinical studies with recombinant TFPI or TM have been carried out showing promising results. The efficacy and safety of other anticoagulants (ie, unfractionated heparin, low-molecular-weight heparin) or transfusion of platelet concentrates or clotting factor concentrates have not been objectively assessed.


Sign in / Sign up

Export Citation Format

Share Document